Literature DB >> 6424512

Nitrous oxide markedly increases cerebral cortical metabolic rate and blood flow in the goat.

D A Pelligrino, D J Miletich, W E Hoffman, R F Albrecht.   

Abstract

Studies to date on the influence of N2O on cerebral blood flow (CBF) and metabolism in dogs, rodents, and humans have produced conflicting results. In the present study the authors have employed techniques in the awake, freely breathing nonstressed goat that allowed the authors to 1) serially obtain rapidly frozen cerebral cortical biopsy specimens (for labile metabolite assay) and 2) measure changes in cerebral O2 metabolism (CMRO2) and total and regional CBF (rCBF). Thus, with each animal utilized as its own control, the authors studied N2O effects on the above variables. Two determinations of the effects of 1 h of N2O (70% via a mask) on these variables were performed on each animal. Following introduction of N2O, PaCO2 and arterial blood pressure did not change, but arterial epinephrine levels declined over the 60-min period. Total CBF increased in the first 5 min of N2O exposure, reached a maximum of 165% control at 15 min, and then decreased to 143% control at 60 min. rCBF evaluations showed that much of this CBF increase was confined to cerebral cortical structures (188-246% control at 60 min). Over the same period cortical CMRO2 increased to 170% of control. No appreciable changes in the levels of high-energy phosphates or glycolytic intermediates were found at 60 min of N2O. The authors attribute the described changes solely to the presence of N2O and not to sympathoadrenal influences, altered ventilation, or anything related to the experimental preparation, and they conclude that N2O (at least in goats) is associated with a marked cerebral cortical "activation".

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6424512     DOI: 10.1097/00000542-198405000-00003

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  9 in total

Review 1.  General anaesthesia for supratentorial neurosurgery.

Authors:  P Ravussin; O Wilder-Smith
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Effect of nitrous oxide use on long-term neurologic and neuropsychological outcome in patients who received temporary proximal artery occlusion during cerebral aneurysm clipping surgery.

Authors:  Jeffrey J Pasternak; Diana G McGregor; William L Lanier; Darrell R Schroeder; Deborah A Rusy; Bradley Hindman; William Clarke; James Torner; Michael M Todd
Journal:  Anesthesiology       Date:  2009-03       Impact factor: 7.892

3.  Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers.

Authors:  Andria Pelentritou; Levin Kuhlmann; John Cormack; Will Woods; Jamie Sleigh; David Liley
Journal:  J Vis Exp       Date:  2018-01-13       Impact factor: 1.355

Review 4.  Anesthesia in Experimental Stroke Research.

Authors:  Ulrike Hoffmann; Huaxin Sheng; Cenk Ayata; David S Warner
Journal:  Transl Stroke Res       Date:  2016-08-17       Impact factor: 6.829

Review 5.  Comparative tolerability profiles of the inhaled anaesthetics.

Authors:  J P Fee; G H Thompson
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606

Review 6.  [Nitrous oxide. Sense or nonsense for today's anaesthesia].

Authors:  M E Schönherr; M W Hollmann; B Graf
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

7.  Alpha-chloralose is a suitable anesthetic for chronic focal cerebral ischemia studies in the rat: a comparative study.

Authors:  Janos Luckl; Jeffrey Keating; Joel H Greenberg
Journal:  Brain Res       Date:  2007-11-28       Impact factor: 3.252

8.  Transcranial Doppler sonography: nitrous oxide and cerebral blood flow velocity in children.

Authors:  J E Leon; B Bissonnette
Journal:  Can J Anaesth       Date:  1991-11       Impact factor: 5.063

9.  Hyperbaric oxygen therapy to improve cognitive dysfunction and encephalatrophy induced by N2O for recreational use: a case report.

Authors:  Dan Luo; Jiajun Xu; Li Hu; Liangming Yu; Leling Xie; Jing Li
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-03       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.